J&J's chemotherapy-free treatment for lung cancer gets US approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. CPRT
5. SPY
6. SEDG
7. ACVA
8. TLT
9. PMTS
10. TENB

Go back to J&J's chemotherapy-free treatment for lung cancer gets US approval
Johnson & Johnson (NYSE: JNJ) Delayed: 266.35 --0 (-0%)
Previous Close $266.35    52 Week High $126.07 
Open $266.35    52 Week Low $94.28 
Day High $266.35    P/E 55.37 
Day Low $266.35    EPS $4.81 
Volume 7,194